Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

India Equity Strategy - Quarterly flipbook: Q4FY22-Cost inflation driving downgrades

Posted On: 2022-06-11 13:51:57 (Time Zone: IST)

Varun Lohchab, Institutional Research Analyst, HDFC Securities.

Q4FY22 earnings season saw an overall in-line performance with wide divergences across sectors and companies. Aggregate revenue/PAT grew by 26%/22% YoY across the HSIE coverage universe (~200 stocks), while they had a three-year CAGR of 11.2%/17.1%. Our coverage universe saw strong YoY growth in the segments of energy, metals, chemicals, lending financials and real estate while infrastructure and cement sectors disappointed. IT continued its steady growth. Common theme across management commentaries was their attempts towards price hikes to counter elevated commodity inflation and freight costs. Various industry players found it challenging to execute it adequately without disturbing demand except few auto & chemical companies.

~54% of our coverage stocks have beaten earnings estimates (vs. ~48% in Q3FY22). Overall, inline performance of the coverage universe with a slight miss of 0.7% was led by energy and infra. Given steep cost inflation expected in 1HFY23, most of the sectors witnessed earning cuts led by energy, IT, industrials, banks and consumers. Consequently, overall earnings estimates witnessed cuts of 4.3% and 4.1% in FY23 & FY24 respectively. For the HSIE coverage universe, both FY23 & FY24 projected earnings growth stands at 13.3% incorporating momentum normalisation & steep cost rise after robust earnings growth in previous two years. Further, Nifty consensus FY23 EPS remains largely unchanged (we see downside risks to this in 1HFY23) and it is trading at ~18.7x FY23 EPS and ~16.1x FY24 EPS.

Sector highlights: Large banks witnessed strong recovery in asset quality and reduced credit cost which made them confident enough to accelerate lending. After a sharp uptick, IT sector growth is reverting to medium term base line. Staple producers felt pinch of inflation as volume growth decelerated and rural was yet to pick up. Price hikes were inadequate to counter inflation. Apparel bounced back to pre-covid level and profitability restored due to price increase and higher full price sales. Footfalls in malls are healthy and spend ticket size has increased. Paints delivered growth in spite of price hikes but jewellery and footwear struggled as cost pass through impacted demand. Chemical producers reported healthy revenue growth and adequate pass through of raw material cost increase. Rise in imported coal price and lower domestic supply created power deficit situation and merchant prices rose. Infrastructure sector enjoyed tailwinds and healthy order book given government's focus on infra projects. Elevated input prices spoiled the party though as risks of margin compression and projects getting delayed rose. Strong pre-sales growth and higher collections witnessed in realty sector which also could absorb partial price hikes. Upstream oil & gas companies reaped the benefits of higher crude & domestic gas realisation and boosted corporate profit pool of India in a meaningful way. After a hiatus, auto sector looked up led by demand pull. Cement producers couldn't push through adequate price hike on concerns of demand derailment.

Our preferred sectors continue to be large cap banks and IT, industrial & real estate, power, autos, gas, insurance, and capital markets, while we remain underweight on consumer (staples & discretionary), NBFCs, and small banks. Model portfolio: We maintain bias towards economy-facing and value sectors.

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Gladiator Stocks - Minda Industries - ICICI Direct

Reliance Industries - Company Update - In fine fettle amidst global uncertainty - BUY

Sector Update - Sugar - ICICI Direct

Initiating Coverage - Hindustan Aeronautics Ltd - ICICI Direct

Rallis India - Company Update - Margin pressure likely to persist in near term..!! - Upgrade to 'BUY'

Indoco Remedies - Q4FY22 Result Update - In-line quarter; strong revenue guidance for US & EU mkt - Upgrade to 'BUY'

Indraprastha Gas - Q4FY22 Result Update - Impressive performance - BUY

KEC International - Annual Report Analysis - Healthy outlook across business segment - Accumulate

Westlife Development - Q4FY22 Result Update - Approaching the tipping point; Buy for LT Gains

Reliance Research downgrades Bajaj Auto to Sell

NOCIL - Q4FY22 Result Update - Strong operating performance amidst challenges - BUY

Gujarat Gas - Company Update - Deftly negotiating through tough times - BUY

Orient Electric - Gaining market share via innovation: initiate with ADD - ICICI Securities

Manappuram Finance - Q4FY22 Result Update - Intense Competition Put Pressure on Yields - BUY

Derivatives Weekly View - June 24, 2022 - ICICI Direct

Stock Tales - Newgen Software - ICICI Direct

Weekly Report - June 25, 2022 - Mr. Mitul Shah - Head of Research at Reliance securities

Gladiator Stocks - Bosch - ICICI Direct

Management Meet Update - Sheela Foam - ICICI Direct

Gladiator Stocks - Mahindra & Mahindra - ICICI Direct

Banks - Modifications to PPI and its impact on cards - Negligible impact, if any, for stocks under coverage

LIC Housing Finance - Q4FY22 Result Update - Fixed rate liabilities could cushion NIM - BUY

Navneet Education - Q4FY22 Result Update - Growth levers in place - BUY

MPC Minutes: Jun-22: All eyes on inflation - Acuité Ratings

Nazara Technologies - Management Meet Update - Breaking through the ESports landscape - BUY

Sector update - Quick Service Restaurants - YES Securities

JK Lakshmi Cement - Q4FY22 Result Update - Strong performance; Valuations drive upgrade - Accumulate

Would it be wise to invest in a home early in your career?

Dr. Reddy's Laboratories - Analyst Meet Update - Multiple growth initiatives - BUY

Dhanuka Agritech - Management Meet Update - 1Q likely to be subdued; all hopes pinned on the monsoons - BUY

BUY Ipca Laboratories - Q4FY22 Result Update - Weak exports; gradual recovery

Acuité expects India's current account deficit to widen to more than USD 90 bn in FY23 - Acuité Macro Pulse

Inflationary concerns will continue to weigh on the pace of economic revival in FY23 - Acuité Macroeconomic Performance index

City Union Bank - Q4FY22 Result Update - Asset quality on the mend - BUY

Banks - BNPL - Early results are not that exciting as yet - Kotak

Acuité expects FY23 GDP growth estimate at 7.5% - Acuité Macro Pulse - Growth - May-22 Edition

Base factor pushes up IIP in Apr-22 to an 8-month high - Acuité Ratings

India Strategy & Q4FY22 Review - Long term growth prospects to overshadow near term uncertainties

FMCG - D2C is here to stay; omni-channel the way forward - HDFC Securities

Automobile Sector - Monthly Quick View - May'22 - Steady Performance Improvement, backed by Gradual Rural Recovery

BFSI - New normal rate cycle; brace for transmission effects - HDFC Securities

SBI Cards and Payment Services - BUY - TP Rs. 1260 - YES SECURITIES

RBI frontloads rate hike amid increased inflationary headwinds - Acuité Ratings

Monetary Policy June 2022 - Axis MF Views

RBI Monetary Policy View - Mr. Dhiraj Relli, MD & CEO, HDFC Securities

Monetary Policy - entering the red zone - Anuj Puri, ANAROCK

Mr. Murali Ramakrishnan, MD &CEO, South Indian Bank on RBI Monetary Policy

Comments on RBI's MPC Policy Jun'22 - Acuité Ratings

Views on RBI Monetary Policy - June 2022

Bayer Cropscience - Q4FY22 Result Update - Healthy all round performance - BUY

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020